Possible Implication of Nrf2, PPAR-γ and MAPKs Signaling in the Protective Role of Mangiferin against Renal Ischemia/Reperfusion in Rats
Mangiferin (Mang) is a known glucosylxanthone that has proven its shielding effect against ischemia/reperfusion (Is/R). However, its full underlying mechanistic perspective against renal Is/R induced lesions is not fully revealed. Consequently, the purpose of this study is to track further non-inves...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_aebb96e7054d4fe6b64502df13645552 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Abdallah M. Gendy |e author |
700 | 1 | 0 | |a Amira A. El-Gazar |e author |
700 | 1 | 0 | |a Ghada M. Ragab |e author |
700 | 1 | 0 | |a Asmaa K. Al-Mokaddem |e author |
700 | 1 | 0 | |a Alaadin E. El-Haddad |e author |
700 | 1 | 0 | |a Heba Mohammed Refat M. Selim |e author |
700 | 1 | 0 | |a Einas Mohamed Yousef |e author |
700 | 1 | 0 | |a Najat O. Hamed |e author |
700 | 1 | 0 | |a Sherihan Salaheldin Abdelhamid Ibrahim |e author |
245 | 0 | 0 | |a Possible Implication of Nrf2, PPAR-γ and MAPKs Signaling in the Protective Role of Mangiferin against Renal Ischemia/Reperfusion in Rats |
260 | |b MDPI AG, |c 2022-12-01T00:00:00Z. | ||
500 | |a 10.3390/ph16010006 | ||
500 | |a 1424-8247 | ||
520 | |a Mangiferin (Mang) is a known glucosylxanthone that has proven its shielding effect against ischemia/reperfusion (Is/R). However, its full underlying mechanistic perspective against renal Is/R induced lesions is not fully revealed. Consequently, the purpose of this study is to track further non-investigated modulatory signals of Mang against the renal Is/R model involving nuclear factor erythroid 2-related factor (Nrf)2/heme oxygenase (HO)-1, peroxisome proliferator-activated receptor (PPAR)-γ/nuclear factor (NF)-κB, p38 mitogen-activated protein kinase (MAPK), and c-Jun N-terminal kinase (JNK) signaling. To ratify our aim, Mang was administrated (20 mg/kg, i.p for seven days) before the induction of bilateral Is/R. Mechanistic maneuver revealed that Mang balanced oxidative state via increasing the expression of the antioxidant Nrf2/HO-1 cue with subsequent enhancement of GSH besides MDA lessening. Additionally, Mang enhanced PPAR-γ mRNA expression and declined <i>p</i>-p38 MAPK and <i>p</i>-JNK expression with concomitant NF-κB downsizing leading to iNOS/NOx and TNF-α rebating. Furthermore, the Mang anti-apoptotic trait was affirmed by enriching Bcl-2 expression as well as decreasing Bax and caspase-3 expression. All these potentials were in the line with the molecular docking results and the improved histopathological findings and renal function biomarkers. Consequently, Mang provided plausible protective mechanisms against renal Is/R-related events, possibly by amending oxidative status, inflammatory mediators, and apoptotic cell death through the involvement of Nrf2, PPAR-γ, MAPK, JNK, and NF-κB signaling. | ||
546 | |a EN | ||
690 | |a mangiferin | ||
690 | |a renal ischemia | ||
690 | |a Nrf2/HO-1 | ||
690 | |a PPAR-γ/NF-κB | ||
690 | |a MAPK/JNK | ||
690 | |a Medicine | ||
690 | |a R | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceuticals, Vol 16, Iss 1, p 6 (2022) | |
787 | 0 | |n https://www.mdpi.com/1424-8247/16/1/6 | |
787 | 0 | |n https://doaj.org/toc/1424-8247 | |
856 | 4 | 1 | |u https://doaj.org/article/aebb96e7054d4fe6b64502df13645552 |z Connect to this object online. |